People

Found 59,456 articles

• Kala Pharmaceuticals Appoints Dr. Francis Mah as Chief Medical Advisor

  3/29/2023

  Kala Pharmaceuticals, Inc. today announced the appointment of Francis Mah, M.D., as Chief Medical Advisor.

• CRISPR Therapeutics Announces Departure of Board Member

  3/29/2023

  CRISPR Therapeutics today announced that Brad Bolzon, Ph.D., Chairman and Managing Director of Versant Ventures, is stepping down from the Board of Directors after nearly a decade of service.

• Axial Therapeutics Announces Key Research and Development Promotions to Advance Clinical and Preclinical Pipeline of Small Molecule Microbiome Therapeutics

  3/29/2023

  Axial Therapeutics today announced key promotions in its research and development organization.

• Prescient Announces Recent Senior Appointments to Its Medical Team

  3/29/2023

  Prescient, a biopharma product and portfolio strategy firm, has announced the recent appointments of Navi Singh Parmar, Michaela Scheiner, and Dr. Sanam Sikander-Rehman as leaders in Prescient Medical.

• Kristin Stafford Joins Novocure Board of Directors

  3/29/2023

  Novocure (NASDAQ: NVCR) today announced that Kristin Stafford has been elected to Novocure’s Board of Directors.

• HanAll Biopharma Assigns Su-jin Park as Co-CEO to Drive Next Phase of Growth

  3/29/2023

  HanAll Biopharma Co., Ltd. (KRX: 009420. KS), a global biopharmaceutical company committed to discovering and developing innovative medicines for patients, announced Su-jin Park has been appointed as new Co-Chief Executive Officer.

• Henry Gosebruch, Former AbbVie EVP and Chief Strategy Officer, Joins ACELYRIN, INC. Board of Directors

  3/29/2023

  ACELYRIN, INC. today announced the appointment of Henry Gosebruch to its board of directors.

• Lavie Bio Announces Appointment of Amit Noam as its Incoming Chief Executive Officer

  3/29/2023

  Lavie Bio Ltd. today is pleased to announce the appointment of Mr. Amit Noam as Chief Executive Officer ("CEO") of Lavie Bio, effective as of April 16, 2023.

• 23andMe Publishes Inaugural Environmental, Social and Governance Report

  3/29/2023

  23andMe Holding Co. today published its inaugural environmental, social and governance (ESG) report.

• Lucy Therapeutics Appoints Neuroscience Drug Discovery and Development Expert Christopher J. Winrow, Ph.D., as Chief Scientific Officer

  3/29/2023

  Lucy Therapeutics, Inc. today announced the appointment of Christopher J. Winrow, Ph.D., a neuroscience and translational medicine expert, as Chief Scientific Officer.

• STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer

  3/29/2023

  STAAR Surgical Company today announced Warren Foust has been named Chief Operating Officer and Magda Michna, Ph.D., has been named Chief Clinical, Regulatory and Medical Affairs Officer.

• Baxter to Host Annual Meeting of Stockholders in Virtual Format

  3/29/2023

  Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2023 Annual Meeting) in a virtual format on Tuesday, May 2, 2023 at 9 a.m., Central Time, as disclosed in Baxter’s proxy statement for the meeting.

• Cystic Fibrosis Foundation Announces Kathryn Brown as Next Chief Communications and Marketing Officer

  3/29/2023

  Today, the Cystic Fibrosis Foundation announced that Kathryn Brown will join the organization as its next Chief Communications and Marketing Officer.

• Codagenix Announces Appointment of Kimber Poffenberger, Ph.D., as Chief Strategy Officer

  3/28/2023

  Codagenix Inc. today announced that Kimber Poffenberger, Ph.D., has been appointed Chief Strategy Officer.

• Virpax Pharmaceuticals Announces Appointment of Barbara A. Ruskin, Ph.D, J.D. to the Board of Directors

  3/28/2023

  Virpax ® Pharmaceuticals, Inc. announced today that the Company has appointed Barbara A. Ruskin, Ph.D, J.D. to its Board of Directors, increasing the size of the Board to nine members.

• Jeff Karp, Ph.D., Joins Eterna’s Scientific Advisory Board

  3/28/2023

  Eterna Therapeutics Inc., a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, announced the appointment of Jeff Karp, Ph.D. to Eterna’s Scientific Advisory Board.

• RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors

  3/28/2023

  RespireRx Pharmaceuticals Inc. (OTC: RSPI) (“RespireRx” or the “Company”) is pleased to announce that on March 22, 2023, Mr. Joseph Siegelbaum was appointed to the Board of Directors as an independent director.

• CereVasc Appoints Dr. Adel Malek Chief Medical Officer

  3/28/2023

  CereVasc, Inc., a privately held, clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, names Adel Malek, MD PhD as the company's Chief Medical Officer.

• Cellino Chief Operating Officer Dr. Abhijit Kulkarni Inducted Into AIMBE’s 2023 College of Fellows

  3/28/2023

  Cellino Biotech, Inc. announced that Chief Operating Officer Abhijit Kulkarni, Ph.D., was inducted to The American Institute for Medical and Biological Engineering College of Fellows.

• Aruna’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, Receives Entrepreneur Distinction from The University System of Georgia Board of Regents

  3/28/2023

  Aruna Bio, Inc. announced that the Company’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, has been named one of the first recipients of Entrepreneur Distinction from The University System of Georgia Board of Regents.